Drawing for IGNYTA

USPTO serial 87260401

IGNYTA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TURNER, JASON FITZGERALD
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IGNYTA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005House mark for pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disordersACTIVE—
042Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research in the fields of treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 22, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 23, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 23, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 15, 2018WOAGWITHDRAWAL OF ATTORNEY GRANTED—
May 15, 2018WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Sep 16, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2017NOACCORRECTED NOA E-MAILED—
Sep 15, 2017EX1GSOU EXTENSION 1 GRANTED—
Sep 15, 2017DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 31, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 15, 2017EXT1SOU EXTENSION 1 FILED—
Aug 15, 2017DRRRDIVISIONAL REQUEST RECEIVED—
Aug 15, 2017ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 15, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 10, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2017DOCKASSIGNED TO EXAMINER—
Dec 12, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 10, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance